The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...

The Family Health Care Institute bulletin (one of King Hussein Foundation's institutes), on this Sunday, discusses nasal and ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...

Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy relief. Here's what you need to know about the safety and risks of using this ...

Women aged 60 years or older had a 32% higher likelihood of CRSsNP diagnosis (OR 1.32). Women had a 37% lower chance of being ...

Cold air, dust and autumn walks can turn a harmless atchoo into a nagging puzzle for worried dog owners. A quick sneeze now ...

Waking up with a stuffy nose is common and usually caused by allergies, nasal inflammation, post-nasal drip, sleep position or structural issues like a deviated septum.

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...